Korro Bio, Inc. (KRRO) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
KRRO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
KRRO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 33.0% | -1366.4% | -1834.5% |
| 2024 | 100.0% | -4047.1% | -3680.4% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | 72.7% | -597.3% | -602.0% |
Download Data
Export KRRO earnings history in CSV or JSON format
Free sign-in required to download data
Korro Bio, Inc. (KRRO) Earnings Overview
As of May 8, 2026, Korro Bio, Inc. (KRRO) reported trailing twelve-month net income of -$113M, reflecting -33.2% year-over-year growth. The company earned $-9.79 per diluted share over the past four quarters, with a net profit margin of -1834.5%.
Looking at the long-term picture, KRRO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$19M in fiscal 2019.
Korro Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BEAM (-$65M net income, -57.2% margin), EDIT (-$160M net income), CRSP (-$569M net income, -16569.8% margin), KRRO has room to improve margins relative to the peer group. Compare KRRO vs BEAM →
KRRO Earnings vs Peers
Earnings metrics vs comparable public companies
KRRO Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$117M | -40.3% | -$87M | $-12.48 | -1834.5% | -1366.4% |
| 2024 | -$84M | -3.0% | -$92M | $-9.37 | -3680.4% | -4047.1% |
| 2023 | -$81M | -39.9% | -$85M | $-53.08 | - | - |
| 2022 | -$58M | +31.5% | -$59M | $-227.42 | - | - |
| 2021 | -$85M | -219.4% | -$84M | $-4.94 | -602.0% | -597.3% |
| 2020 | -$27M | -41.4% | -$28M | $-41.10 | -71.7% | -74.5% |
| 2019 | -$19M | +2.2% | -$21M | $-30.39 | -64.8% | -71.4% |
| 2018 | -$19M | +5.3% | -$19M | $-30.57 | - | - |
| 2017 | -$20M | - | -$16M | $-32.27 | - | - |
See KRRO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KRRO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KRRO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKRRO — Frequently Asked Questions
Quick answers to the most common questions about buying KRRO stock.
Is KRRO growing earnings?
KRRO EPS fell to $-9.79, with earnings declining -33.2%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-113M.
What are KRRO's profit margins?
Korro Bio, Inc. net margin is -1834.5%, with operating margin at -1366.4%. Below-average margins reflect competitive or cost pressures.
How consistent are KRRO's earnings?
KRRO earnings data spans 2017-2025. The declining earnings trend is -33.2% YoY. Historical data enables comparison across business cycles.